Barclays
ABMD

Barclays’s Abiomed Inc ABMD Stock Holding History

Barclays’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,500
Closed -$3.74M – 5236
2020
Q3 		$3.74M Buy
+13,500
New +$3.89M ﹤0.01% 1603
2020
Q2 		– Sell
-1,300
Closed -$189K – 6436
2020
Q1 		$189K Sell
1,300
-26,200
-95% -$4.35M ﹤0.01% 4346
2019
Q4 		$4.69M Buy
27,500
+26,200
+2,015% +$4.86M ﹤0.01% 2068
2019
Q3 		$231K Sell
1,300
-29,700
-96% -$6.42M ﹤0.01% 4862
2019
Q2 		$8.07M Buy
+31,000
New +$8.23M ﹤0.01% 1496
2019
Q1 		– Sell
-2,200
Closed -$715K – 7449
2018
Q4 		$715K Buy
2,200
+2,000
+1,000% +$695K ﹤0.01% 3457
2018
Q3 		$90K Buy
+200
New +$78.8K ﹤0.01% 5648
2018
Q2 		– Sell
-1,200
Closed -$349K – 7414
2018
Q1 		$349K Buy
1,200
+200
+20% +$50.7K ﹤0.01% 4323
2017
Q4 		$187K Buy
+1,000
New +$187K ﹤0.01% 4748
2014
Q4 		– Sell
-1,200
Closed -$29K – 7697
2014
Q3 		$29K Sell
1,200
-300
-20% -$7.6K ﹤0.01% 6252
2014
Q2 		$38K Buy
1,500
+1,200
+400% +$27.9K ﹤0.01% 6137
2014
Q1 		$8K Buy
+300
New +$8.3K ﹤0.01% 7039
2013
Q4 		– Sell
-200
Closed -$4K – 7736
2013
Q3 		$4K Sell
200
-4,700
-96% -$107K ﹤0.01% 7056
2013
Q2 		$106K Buy
+4,900
New +$98.5K ﹤0.01% 5746

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Barclays's ABMD Position: Q4 2022 in Review

Barclays sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 50,218 shares — an estimated $12.3M sold.

Barclays first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $29.2M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Barclays reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 50,218 Abiomed Inc shares in Q4 2022, an estimated $12.3M.
  • Barclays first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • Barclays's Abiomed Inc position peaked at $29.2M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.